SCHEMBL7186996

SCHEMBL7186996

CCCOc1c(CCC)cc(CCC)c(O)c1C=CC(=O)c1ccc(N)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.44
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
KRAS P01116 1/20 0.42
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
DPP4 P27487 2/20 0.39
CYP1B1 Q16678 3/20 0.39
CYP1A1 P04798 2/20 0.39
PTPN1 P18031 1/20 0.39
CYP3A4 P08684 2/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
NFKB1 P19838 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
NFKB2 Q00653 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7186990 1.00 ABCG2 (0.44) ABCG2CA1CA2KRASCTSL
SCHEMBL9198700 0.97 ABCG2 (0.42) ABCG2CA1CA2KRASCTSL
SCHEMBL9198704 0.97 ABCG2 (0.42) ABCG2CA1CA2KRASCTSL
SCHEMBL7180148 0.92 CA1 (0.43) ABCG2CA1CA2KRASCTSL
SCHEMBL7180145 0.92 CA1 (0.43) ABCG2CA1CA2KRASCTSL
SCHEMBL7187412 0.91 ABCG2 (0.46) ABCG2CA1CA2KRASCTSL
SCHEMBL7187408 0.91 ABCG2 (0.46) ABCG2CA1CA2KRASCTSL
SCHEMBL7184788 0.91 ABCG2 (0.54) ABCG2CTSLCTSBDPP4CYP1B1
SCHEMBL7184784 0.91 ABCG2 (0.54) ABCG2CTSLCTSBDPP4CYP1B1
SCHEMBL7190226 0.89 ABCG2 (0.42) ABCG2CA1CA2KRASCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed